Are you Dr. Stechschulte?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3651 College Blvd
Ste 100B
Leawood, KS 66211Phone+1 913-362-0031Fax+1 913-253-1766
Summary
- Dr. Daniel Stechschulte Jr., MD is a board certified orthopedic surgeon in Leawood, Kansas. He is currently licensed to practice medicine in Kansas, New Mexico, and Vermont. He is affiliated with Kansas City Orthopaedic Institute and AdventHealth Shawnee Mission.
Education & Training
New York Presbyterian HospitalFellowship, Sports Medicine (Physical Medicine And Rehabilitation), 1997 - 1998
University of WashingtonResidency, Orthopaedic Surgery, 1993 - 1997
Virginia Mason Franciscan HealthInternship, Transitional Year, 1991 - 1992
University of Kansas School of MedicineClass of 1991
Certifications & Licensure
KS State Medical License 1998 - 2025
NM State Medical License 2015 - 2015
NY State Medical License 1997 - 1999
VT State Medical License 1998 - 1998
WA State Medical License 1995 - 1997- American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Vitamin A, Its Receptors and Asthma Start of enrollment: 2008 May 01
Publications & Presentations
PubMed
- Repair of Subacute Intrasubstance Rupture of the Biceps Brachii in a 16-Year-Old Patient.Joshua T Lackey, Erin P Murray, Mark J Winston, Daniel J Stechschulte Jr
Journal of Hand Surgery Global Online. 2022-09-01 - 36 citationsMast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice.Donald D. Smith, Xiaoyu Tan, Vineesh V. Raveendran, Ossama Tawfik, Daniel J. Stechschulte
American Journal of Physiology. Heart and Circulatory Physiology. 2012-06-15 - 10 citationsHuman mast cells (HMC-1 5C6) enhance interleukin-6 production by quiescent and lipopolysaccharide-stimulated human coronary artery endothelial cells.Damandeep Walia, Mukut Sharma, Vineesh V. Raveendran, Jianping Zhou, Ram Sharma
Mediators of Inflammation. 2012-01-26
